Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma
Case Reports in Endocrinology · 2011
DOI: 10.1155/2011/342480 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Endocrinology, 2011. Verfasst von Usman Hammawa Malabu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Townsville Hospital, 100 Angus Smith Drive, Douglas QLD 4814, Australia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
We present a case of highly elevated tenfold rise of serum chromogranin A in a young, morbidly obese, hypertensive female being investigated for pancreatic mass, weight loss, and elevated ESR. Following extensive noninvasive investigations, an ultrasound-guided pancreatic biopsy confirmed benign haemorrhagic cyst. A clue to the etiology of the hyperchromogranin A was the elevated serum gastrin level leading to suspicion of proton pump inhibitor administration confirmed by admittance to its use. Withdrawal of the medication led to dramatic resolution of the neuroendocrine tumor marker.
Autor:innen und Institutionen
- Department of Endocrinology, Townsville Hospital, 100 Angus Smith Drive, Douglas QLD 4814, Australia.
Zitieren
APA
Malabu, U. H., Karamatic, R., Mahy, G., & Sangla, K. S. (2011). Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma. Case Reports in Endocrinology. https://doi.org/10.1155/2011/342480
Vancouver
Malabu UH, Karamatic R, Mahy G, Sangla KS. Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma. Case Reports in Endocrinology. 2011. doi:10.1155/2011/342480
BibTeX
@article{Malabu2011,
author = {Malabu, Usman Hammawa and Karamatic, Rozemary and Mahy, Gillian and Sangla, Kunwarjit Singh},
title = {Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma},
journal = {Case Reports in Endocrinology},
year = {2011},
doi = {10.1155/2011/342480}
}
EUVIMED